2026년 5월 18일 월요일

HPSP(403870) Company Analysis — High-Pressure Annealing Equipment Monopoly and Valuation Review 2026

HPSP(403870) Analysis: High-Pressure Annealing Equipment Monopoly Structure and 2026 Earnings Trajectory

HPSP is the world's only mass-production supplier of high-pressure annealing (HPA) equipment for semiconductor processes, listed on KOSDAQ. The company maintained an operating profit margin of 50.5% in Q1 2026 — even during the off-season — and is positioned for sequential quarterly earnings improvement in the second half as its customer base expands.


1. Company Overview and Core Business

HPSP (403870) is a KOSDAQ-listed company specializing in the manufacture of High-Pressure Annealing (HPA) equipment used for film-defect healing in semiconductor processes. Foreign ownership stands at 30.60%, with the largest shareholder being Hit2025 Holdings Co., Ltd. (20.46%). In Q1 2026, the company recorded revenue of KRW 31.9 billion (≈$21.3M) and operating profit of KRW 16.1 billion (≈$10.8M), achieving an operating profit margin (OPM) of 50.5%; EPS of KRW 292 (≈$0.20) beat the market consensus of KRW 257 (≈$0.17) by 13.8%. On an annual basis, building on 2025 revenue of KRW 173.0 billion (≈$115.7M) and operating profit of KRW 89.9 billion (≈$60.1M) (OPM 52.0%), 2026 revenue of KRW 240.2 billion (≈$160.7M) and operating profit of KRW 129.6 billion (≈$86.7M) (OPM 53.9%) are projected.*1

📌 1Q26 OPM 50.5% — Profitability maintained above 50% even in the off-season; EPS beat consensus by 13.8%

2. Core Product Competitiveness Analysis

HPA equipment is seeing broader adoption across logic and foundry segments driven by tightening film uniformity requirements as process nodes shrink (2/3/4nm). Revenue from logic/foundry-facing equipment is projected to grow from approximately KRW 90 billion (≈$60.2M) in 2025 to KRW 124.4 billion (≈$83.2M) in 2026.*1 The NAND customer base is set to expand from 1 in 2025 to 4 in 2026 and 5 in 2027, marking broad entry across major NAND suppliers.*2 Looking ahead, high-pressure oxide film equipment (currently in Beta testing) and Hybrid Bonding process applications represent mid-term product diversification pathways.

CategoryDetails
PositionWorld's sole mass-production supplier of High-Pressure Annealing (HPA) equipment
Competitive Advantage50%+ operating margins, supply across logic and memory applications, ongoing annual expansion of customer base
Competitive DisadvantageConcentration in a single core product, quarterly volatility tied to the leading customer's capex cycle

3. Valuation Analysis

As of May 17, 2026, at a share price of KRW 52,200 (≈$34.9), Trailing PER of 60.0x, Forward PER of 40.0x, and PBR of 13.70x are applied. The decline in Forward PER relative to Trailing PER (60x → 40x) reflects the earnings recovery outlook toward a 2026 EPS of KRW 1,416 (≈$0.9).*1 Although 2025 EPS of KRW 870 (≈$0.6) declined from the prior year's KRW 1,040 (≈$0.7), quarterly earnings growth is expected to resume from 2026 onward.*1 Target prices from major securities firms are distributed in the KRW 60,000–65,000 (≈$40.1–$43.5) range,*3 and the premium to the average Fwd P/E of global semiconductor equipment peers is attributable to the company's monopolistic supply position and profitability level.

📌 A Forward PER of 40x reflects the earnings growth recovery outlook, though it remains elevated in absolute terms within the sector
MetricCurrentSector Avg.Interpretation
Trailing PER60.0xN/ABased on 2025 EPS of KRW 870 (≈$0.6)
Forward PER40.0xN/ABased on 2026 EPS of KRW 1,416 (≈$0.9)*1
PBR13.70xN/APremium structure relative to ROE of 33.8%*1

4. Risk Factors & Monitoring Points

Quarterly earnings volatility may arise depending on the timing of capex execution and process transition by the primary customer. High concentration in a single core technology (HPA) creates structural vulnerability should an alternative process technology emerge. Some impact from rising raw material costs was confirmed in 1Q26, and the role of FX fluctuations as a margin-defense variable also warrants continued monitoring.

  • ⚠️ Quarterly revenue volatility from delays in the primary customer's capex cycle
  • ⚠️ Risk of disruption to the monopolistic supply structure should an alternative to the high-pressure annealing (HPA) process emerge
  • 📌 Confirm whether DRAM 1d process development is completed (3Q26 target) and track the number of test equipment orders received
  • 📌 Monitor whether quarterly operating profit margin holds above the 50% threshold — verify the path to achieving annual OPM of 53% or higher

5. Recent DART Filings

As of the analysis reference date (2026-05-18), no DART filings directly related to business operations or financial structure have been identified.

HPSP is on a path to expand order wins across logic and memory end markets, underpinned by its monopoly supply position in high-pressure annealing equipment, while sustaining an OPM of 50.5% in the Q1 2026 off-season. Whether DRAM 1d test equipment orders materialize and the pace of NAND customer additions will be the key variables driving future earnings.


📎 References & Estimation Basis

  1. *1 Daeshin Securities Research Center report dated 2026.05.18 — 2026F revenue KRW 240.2B (≈$160.7M), operating profit KRW 129.6B (≈$86.7M) (OPM 53.9%), EPS KRW 1,416 (≈$0.95), ROE 33.8%, logic/foundry equipment revenue KRW 124.4B (≈$83.2M), 2027F EPS KRW 1,765 (≈$1.18)
  2. *2 Based on Daeshin Securities and Samsung Securities 2026 analyses — NAND-facing customer count: 1 in 2025 → 4 in 2026 → 5 in 2027 (projected)
  3. *3 NH Investment Securities target price KRW 65,000 (≈$43.5) (Buy) as of 2026.05.06; Samsung Securities target price KRW 60,000 (≈$40.1) as of 2026.05.15; Daeshin Securities target price KRW 63,000 (≈$42.1) (Buy) as of 2026.05.18 — listed for reference only; not a solicitation to buy or sell
  4. *4 USD equivalents (≈$) are approximate, calculated at 1 USD = 1,495 KRW (as of 2026-05-18, source: Yahoo Finance).

본 보고서는 정보 제공 목적이며 투자 권유가 아닙니다. 투자 결정은 본인 책임입니다.

⚠️ 본 포스트는 투자 참고용 정보이며, 투자 권유가 아닙니다. 모든 투자 판단과 책임은 투자자 본인에게 있습니다.

댓글 없음:

댓글 쓰기

Hyundai Glovis (086280) Company Analysis 2026: PCTC & CKD Growth and Valuation

Hyundai Glovis (086280) In-Depth Analysis: PCTC Fleet Expansion and Emerging-Market CKD Volume Drive 2026 Revenue Forecast Above KRW 32T (≈...